Exelixis Stock Price

0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Exelixis Inc EXEL NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-0.02 -0.09% 23.48 23.32 23.79 23.42 23.50 20:00:00
Bid Price Ask Price Spread Spread % News
22.71 24.30 1.59 6.54% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
12,177 1,383,552 $ 23.48 $ 32,488,987 2,657,657 13.67 - 27.90
Last Trade Time Type Quantity Stock Price Currency
19:35:24 79 $ 23.48 USD

Exelixis Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 7.20B 306.66M 270.91M $ 967.78M $ 281.33M 1.02 25.30
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Exelixis News

Date Time Source News Article
6/30/202008:00Business WireExelixis Announces Initiation of CONTACT-02 Phase 3 Pivotal..
6/18/202016:05Business WireExelixis to Webcast Virtual Fireside Chat as Part of the..
6/11/202008:00Business WireExelixis Announces Initiation of CONTACT-01 Phase 3 Pivotal..
6/03/202016:05Business WireExelixis to Webcast Fireside Chats as Part of Virtual..
5/22/202017:21Edgar (US Regulatory)Current Report Filing (8-k)
5/13/202017:00Business WireExelixis Announces Results From COSMIC-021 Trial of..
5/12/202006:02Edgar (US Regulatory)Current Report Filing (8-k)
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical EXEL Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week23.5024.2722.4523.422,401,967-0.02-0.09%
1 Month23.1424.4821.2023.172,550,6600.341.47%
3 Months18.7527.9017.5424.203,385,5944.7325.23%
6 Months17.7127.9013.6720.733,571,3735.7732.58%
1 Year21.5227.9013.6719.753,067,2811.969.11%
3 Years24.6832.5013.4221.683,334,745-1.20-4.86%
5 Years3.4832.503.3116.214,038,17720.00574.71%

Exelixis Description

Exelixis is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its lead molecule cabozantinib is indicated for the treatment of patients with metastatic medullary thyroid cancer (as Cometriq) and advanced renal cell carcinoma, or kidney cancer, and hepatocellular carcinoma, or liver cancer (as Cabometyx). Exelixis and partner Roche have also brought Cotellic to market for the treatment of melanoma.
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200706 05:23:57